Summary & Overview
HCPCS Level II J1100: Dexamethasone Injection, 1 mg
HCPCS Level II code J1100 designates a 1 mg unit of dexamethasone sodium phosphate for injection, a commonly used corticosteroid in outpatient and procedural settings. Nationally, accurate reporting of injectable drug units like J1100 matters for clinical documentation, drug utilization measurement, and claims adjudication given variation in payer coverage policies and drug administration settings.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for dexamethasone injections, common sites of service where this HCPCS code is used, and the typical payer landscape. The publication also outlines benchmarking points and relevant policy considerations affecting reimbursement and claims processing for injectable pharmaceuticals billed with HCPCS Level II codes.
This summary provides practical reference material for billing and revenue cycle teams, clinicians who order injectable corticosteroids, and policy analysts tracking outpatient drug coding and coverage trends.
Billing Code Overview
HCPCS Level II code J1100 represents an injection of dexamethasone sodium phosphate, 1 mg. This code is used to report the administration of the specified corticosteroid formulation in a single-measure dosing unit.
Service Type: Medication administration / injectable drug
Typical Site of Service: Outpatient clinic, physician office, or hospital outpatient department
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an outpatient clinic, urgent care center, or emergency department with moderate to severe inflammatory symptoms such as acute gout flare, allergic reaction, severe asthma exacerbation, or localized inflammatory pain requiring corticosteroid therapy. A clinician assesses the patient, documents the diagnosis (for example, acute gout M10.9, allergic reaction T78.2X1A, or asthma exacerbation J45.901), obtains consent for an intramuscular or intra-articular corticosteroid injection, verifies allergies and current medications, and prepares dexamethasone sodium phosphate for administration. The medication is drawn in the appropriate dose (multiples of 1 mg per J1100 unit), administered via intramuscular, intra-articular, or soft-tissue injection depending on indication, and the patient is observed briefly for adverse reactions. Post-procedure documentation includes medication name and strength, route, site, lot number, consent, and any immediate patient response. Billing uses HCPCS Level II code J1100 per 1 mg unit and may include an appropriate CPT code for the injection procedure or evaluation/management code if separately billable.
Coding Specifications
| Modifier | Description |
|---|